- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The 340B Drug Discount Program Needs Protection, Health Systems Urge Congress
While there's been controversy around the drug discount program for some time, the Health Resources and Services Administration plans to release a "mega-guidance" that will address several aspects of the 340B program.
Leaders of hospital and health systems across the country have urged members of Congress to protect the 340B drug discount program that is a backbone for hospitals that serve low-income Medicare and Medicaid patients. Additionally, the American Hospital Administration has expressed concerns about certain provisions within the 21st Century Cures Act, released by the House Energy and Commerce Committee.
Read the article on H&HN: http://bit.ly/1Hi4ZhU
From MSSP ACOs to Employer Value: Translating Value-Based Principles to Self-Insured Plans
December 12th 2025Value-based care adoption in employer insurance requires replacing fragmented point solutions with unified, at-risk performance contracts that align vendors, providers, and members around total cost and quality goals.
Read More
From Complexity to Clarity: A Path to Value in Employer Health Plans
December 12th 2025Employers struggle to define value from health care spending amid complexity and misaligned incentives. Achieving measurable outcomes requires transparency, incentive realignment, and gradual, employee-centered change.
Read More
